Comparing Arcalyst vs Ilaris
| Arcalyst (rilonacept) | Ilaris (canakinumab) |
|
|---|
| Arcalyst (rilonacept) | Ilaris (canakinumab) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Pericarditis, Familial Cold Autoinflammatory Syndrome, Cryopyrin-Associated Periodic Syndromes, Muckle Wells Syndrome, Interleukin-1 Receptor Antagonist Deficiency. Arcalyst may also... View more |
Prescription only
Ilaris (canakinumab) is an injected biologic medicine known as a monoclonal antibody that blocks certain proteins in the body. It is injected subcutaneously (under the skin) by a doctor or home... View more |
Related suggestions Familial Cold Autoinflammatory Syndrome
Cryopyrin-Associated Periodic Syndromes
Muckle Wells Syndrome
Popular comparisons
|
|||||||
| More about Arcalyst (rilonacept) | More about Ilaris (canakinumab) | ||||||||
| Ratings & Reviews | |||||||||
|
Arcalyst has an average rating of 10.0 out of 10 from a total of 6 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Ilaris has an average rating of 10.0 out of 10 from a total of 5 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
|
View all Arcalyst side effects |
View all Ilaris side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
N/A |
||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Arcalyst prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | |||||||||
|
|
||||||||
| Brand Names | |||||||||
|
N/A |
N/A |
||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
N/A |
624 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 518 drugs are known to interact with Arcalyst:
|
A total of 518 drugs are known to interact with Ilaris:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
February 27, 2008 |
June 17, 2009 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Actemra
Actemra is used to treat COVID-19, rheumatoid arthritis, systemic juvenile idiopathic arthritis ...
Adbry
Adbry is used to treat moderate-to-severe atopic dermatitis (eczema) in adults and children aged 12 ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Bimzelx
Bimzelx (bimekizumab) treats plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and ...
Cinqair
Cinqair (reslizumab) is a monoclonal antibody that affects the actions of the body's immune system ...
Cosentyx
Cosentyx (secukinumab) is used to treat plaque psoriasis, psoriatic arthritis, ankylosing ...
Ebglyss
Ebglyss (lebrikizumab) is a treatment for moderate-to-severe atopic dermatitis given as a monthly ...
Enspryng
Enspryng is used to treat neuromyelitis optica spectrum disorder (NMOSD) in adults who are ...
Fasenra
Fasenra injection is used to treat severe eosinophilic asthma in adults and children aged 6 and ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.